XOMA (US) LLC to Announce Second Quarter 2012 Financial Results and Host Webcast on August 7
BERKELEY, Calif., July 24, 2012 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced the Company will host a webcast conference call on Tuesday, August 7, 2012 at 4:30 p.m. Eastern time to discuss second quarter 2012 financial results and provide an update on gevokizumab's global Phase 3 and Phase 2 clinical programs.